APO Research
Talk to an analyst

APO RESEARCH · REPORT

Veterinary Therapeutics

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Veterinary Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025198 pages

Choose your research edition.

Industry ResearchVeterinary Therapeutics Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary Therapeutics Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Veterinary Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary Therapeutics Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary Therapeutics Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Veterinary Therapeutics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Veterinary Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Veterinary Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Veterinary Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Veterinary Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Veterinary Therapeutics include CAHIC, Zoetis, Ringpu Biology, Merck, Virbac, Vetoquinol, Phibro, Ouro Fino Saude and Orion, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Veterinary Therapeutics market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Veterinary Therapeutics and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Veterinary Therapeutics revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Veterinary Therapeutics market size, projected growth trends, production technologies, key applications, and end-use industries.

Veterinary Therapeutics Segment by Company

CAHIC

Zoetis

Ringpu Biology

Merck

Virbac

Vetoquinol

Phibro

Ouro Fino Saude

Orion

Norbrook

Nippon Zenyaku Kogyo

Huvepharma

Hipra

Farmavet-Pasteur

Elanco

Dechra

Ceva

Boehringer Ingelheim

Veterinary Therapeutics Segment by Type

Analgesics

Sedatives

Anti-Inflammatory

Parasiticides

Anti-Infectives

Others

Veterinary Therapeutics Segment by Application

Swine

Cattle

Poultry

Pets

Others

Veterinary Therapeutics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Veterinary Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Veterinary Therapeutics industry.

Chapter 3: Detailed analysis of Veterinary Therapeutics companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Veterinary Therapeuticsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Veterinary Therapeutics Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Analgesics Table 3. Key Players of Sedatives Table 4. Key Players of Anti-Inflammatory Table 3. Key Players of Parasiticides Table 4. Key Players of Anti-Infectives Table 5. Key Players of Others Table 6. Global Veterinary Therapeutics Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 7. Key Players of Swine Table 8. Key Players of Cattle Table 9. Key Players of Poultry Table 10. Key Players of Pets Table 11. Key Players of Others Table 12. Global Veterinary Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Veterinary Therapeutics Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Veterinary Therapeutics Market Share by Region (2021-2026) Table 15. Global Veterinary Therapeutics Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Veterinary Therapeutics Market Share by Region (2027-2032) Table 17. Veterinary Therapeutics Industry Trends Table 18. Veterinary Therapeutics Industry Drivers Table 19. Veterinary Therapeutics Industry Opportunities and Challenges Table 20. Veterinary Therapeutics Industry Restraints Table 21. Global Veterinary Therapeutics Revenue by Company (US$ Million) & (2021-2026) Table 22. Global Veterinary Therapeutics Revenue Market Share by Company (2021-2026) Table 23. Global Veterinary Therapeutics Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 24. Global Veterinary Therapeutics Key Company Head Office and Area Served Table 25. Global Veterinary Therapeutics Company, Product Type & Application Table 26. Global Veterinary Therapeutics Company Establishment Date Table 27. Global Company Market Concentration Ratio (CR5 and HHI) Table 28. Global Veterinary Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 29. Global Veterinary Therapeutics Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Veterinary Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 31. Global Veterinary Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 32. Global Veterinary Therapeutics Revenue Market Share by Type (2021-2026) Table 33. Global Veterinary Therapeutics Revenue Market Share by Type (2027-2032) Table 34. Global Veterinary Therapeutics Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Veterinary Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 36. Global Veterinary Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 37. Global Veterinary Therapeutics Revenue Market Share by Application (2021-2026) Table 38. Global Veterinary Therapeutics Revenue Market Share by Application (2027-2032) Table 39. CAHIC Company Information Table 40. CAHIC Business Overview Table 41. CAHIC Veterinary Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. CAHIC Veterinary Therapeutics Product Portfolio Table 43. CAHIC Recent Development Table 44. Zoetis Company Information Table 45. Zoetis Business Overview Table 46. Zoetis Veterinary Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Zoetis Veterinary Therapeutics Product Portfolio Table 48. Zoetis Recent Development Table 49. Ringpu Biology Company Information Table 50. Ringpu Biology Business Overview Table 51. Ringpu Biology Veterinary Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Ringpu Biology Veterinary Therapeutics Product Portfolio Table 53. Ringpu Biology Recent Development Table 54. Merck Company Information Table 55. Merck Business Overview Table 56. Merck Veterinary Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Merck Veterinary Therapeutics Product Portfolio Table 58. Merck Recent Development Table 59. Virbac Company Information Table 60. Virbac Business Overview Table 61. Virbac Veterinary Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Virbac Veterinary Therapeutics Product Portfolio Table 63. Virbac Recent Development Table 64. Vetoquinol Company Information Table 65. Vetoquinol Business Overview Table 66. Vetoquinol Veterinary Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Vetoquinol Veterinary Therapeutics Product Portfolio Table 68. Vetoquinol Recent Development Table 69. Phibro Company Information Table 70. Phibro Business Overview Table 71. Phibro Veterinary Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Phibro Veterinary Therapeutics Product Portfolio Table 73. Phibro Recent Development Table 74. Ouro Fino Saude Company Information Table 75. Ouro Fino Saude Business Overview Table 76. Ouro Fino Saude Veterinary Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Ouro Fino Saude Veterinary Therapeutics Product Portfolio Table 78. Ouro Fino Saude Recent Development Table 79. Orion Company Information Table 80. Orion Business Overview Table 81. Orion Veterinary Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Orion Veterinary Therapeutics Product Portfolio Table 83. Orion Recent Development Table 84. Norbrook Company Information Table 85. Norbrook Business Overview Table 86. Norbrook Veterinary Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Norbrook Veterinary Therapeutics Product Portfolio Table 88. Norbrook Recent Development Table 89. Nippon Zenyaku Kogyo Company Information Table 90. Nippon Zenyaku Kogyo Business Overview Table 91. Nippon Zenyaku Kogyo Veterinary Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 92. Nippon Zenyaku Kogyo Veterinary Therapeutics Product Portfolio Table 93. Nippon Zenyaku Kogyo Recent Development Table 94. Huvepharma Company Information Table 95. Huvepharma Business Overview Table 96. Huvepharma Veterinary Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 97. Huvepharma Veterinary Therapeutics Product Portfolio Table 98. Huvepharma Recent Development Table 99. Hipra Company Information Table 100. Hipra Business Overview Table 101. Hipra Veterinary Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 102. Hipra Veterinary Therapeutics Product Portfolio Table 103. Hipra Recent Development Table 104. Farmavet-Pasteur Company Information Table 105. Farmavet-Pasteur Business Overview Table 106. Farmavet-Pasteur Veterinary Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 107. Farmavet-Pasteur Veterinary Therapeutics Product Portfolio Table 108. Farmavet-Pasteur Recent Development Table 109. Elanco Company Information Table 110. Elanco Business Overview Table 111. Elanco Veterinary Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 112. Elanco Veterinary Therapeutics Product Portfolio Table 113. Elanco Recent Development Table 114. Dechra Company Information Table 115. Dechra Business Overview Table 116. Dechra Veterinary Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 117. Dechra Veterinary Therapeutics Product Portfolio Table 118. Dechra Recent Development Table 119. Ceva Company Information Table 120. Ceva Business Overview Table 121. Ceva Veterinary Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 122. Ceva Veterinary Therapeutics Product Portfolio Table 123. Ceva Recent Development Table 124. Boehringer Ingelheim Company Information Table 125. Boehringer Ingelheim Business Overview Table 126. Boehringer Ingelheim Veterinary Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 127. Boehringer Ingelheim Veterinary Therapeutics Product Portfolio Table 128. Boehringer Ingelheim Recent Development Table 129. North America Veterinary Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 130. North America Veterinary Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 131. North America Veterinary Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 132. North America Veterinary Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 133. North America Veterinary Therapeutics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. North America Veterinary Therapeutics Market Size by Country (2021-2026) Table 135. North America Veterinary Therapeutics Market Size by Country (2027-2032) Table 136. Europe Veterinary Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 137. Europe Veterinary Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 138. Europe Veterinary Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 139. Europe Veterinary Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 140. Europe Veterinary Therapeutics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. Europe Veterinary Therapeutics Market Size by Country (2021-2026) Table 142. Europe Veterinary Therapeutics Market Size by Country (2027-2032) Table 143. China Veterinary Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 144. China Veterinary Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 145. China Veterinary Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 146. China Veterinary Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 147. Asia Veterinary Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 148. Asia Veterinary Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 149. Asia Veterinary Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 150. Asia Veterinary Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 151. Asia Veterinary Therapeutics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 152. Asia Veterinary Therapeutics Market Size by Country (2021-2026) Table 153. Asia Veterinary Therapeutics Market Size by Country (2027-2032) Table 154. South America, Middle East & Africa Veterinary Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 155. South America, Middle East & Africa Veterinary Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 156. South America, Middle East & Africa Veterinary Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 157. South America, Middle East & Africa Veterinary Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 158. South America, Middle East & Africa Veterinary Therapeutics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. South America, Middle East & Africa Veterinary Therapeutics Market Size by Country (2021-2026) Table 160. South America, Middle East & Africa Veterinary Therapeutics Market Size by Country (2027-2032) Table 161. Research Programs/Design for This Report Table 162. Authors List of This Report Table 163. Secondary Sources Table 164. Primary Sources List of Figures Figure 1. Veterinary Therapeutics Product Image Figure 2. Global Veterinary Therapeutics Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Veterinary Therapeutics Market Share by Type: 2025 VS 2032 Figure 4. Analgesics Image Figure 5. Sedatives Image Figure 6. Anti-Inflammatory Image Figure 7. Parasiticides Image Figure 8. Anti-Infectives Image Figure 9. Others Image Figure 10. Global Veterinary Therapeutics Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 11. Global Veterinary Therapeutics Market Share by Application: 2025 VS 2032 Figure 12. Swine Image Figure 13. Cattle Image Figure 14. Poultry Image Figure 15. Pets Image Figure 16. Others Image Figure 17. Global Veterinary Therapeutics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Veterinary Therapeutics Market Size (2021-2032) & (US$ Million) Figure 19. Global Veterinary Therapeutics Market Share by Region: 2025 VS 2032 Figure 20. Years Considered Figure 21. Global Veterinary Therapeutics Market Share by Players in 2025 Figure 22. Global Top 5 and 10 Veterinary Therapeutics Players Market Share by Revenue in 2025 Figure 23. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 24. Global Veterinary Therapeutics Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Veterinary Therapeutics Revenue Market Share by Type (2021-2032) Figure 26. Global Veterinary Therapeutics Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Veterinary Therapeutics Revenue Market Share by Application (2021-2032) Figure 28. North America Veterinary Therapeutics Market Size (2021-2032) & (US$ Million) Figure 29. North America Veterinary Therapeutics Market Share by Type (2021-2032) Figure 30. North America Veterinary Therapeutics Market Share by Application (2021-2032) Figure 31. North America Veterinary Therapeutics Market Share by Country (2021-2032) Figure 32. United States Veterinary Therapeutics Market Size (2021-2032) & (US$ Million) Figure 33. Canada Veterinary Therapeutics Market Size (2021-2032) & (US$ Million) Figure 34. Mexico Veterinary Therapeutics Market Size (2021-2032) & (US$ Million) Figure 35. Europe Veterinary Therapeutics Market Size (2021-2032) & (US$ Million) Figure 36. Europe Veterinary Therapeutics Market Share by Type (2021-2032) Figure 37. Europe Veterinary Therapeutics Market Share by Application (2021-2032) Figure 38. Europe Veterinary Therapeutics Market Share by Country (2021-2032) Figure 39. Germany Veterinary Therapeutics Market Size (2021-2032) & (US$ Million) Figure 40. France Veterinary Therapeutics Market Size (2021-2032) & (US$ Million) Figure 41. U.K. Veterinary Therapeutics Market Size (2021-2032) & (US$ Million) Figure 42. Italy Veterinary Therapeutics Market Size (2021-2032) & (US$ Million) Figure 43. Russia Veterinary Therapeutics Market Size (2021-2032) & (US$ Million) Figure 44. Nordic Countries Veterinary Therapeutics Market Size (2021-2032) & (US$ Million) Figure 45. China Veterinary Therapeutics Market Size (2021-2032) & (US$ Million) Figure 46. China Veterinary Therapeutics Market Share by Type (2021-2032) Figure 47. China Veterinary Therapeutics Market Share by Application (2021-2032) Figure 48. Asia Veterinary Therapeutics Market Size (2021-2032) & (US$ Million) Figure 49. Asia Veterinary Therapeutics Market Share by Type (2021-2032) Figure 50. Asia Veterinary Therapeutics Market Share by Application (2021-2032) Figure 51. Asia Veterinary Therapeutics Market Share by Country (2021-2032) Figure 52. Japan Veterinary Therapeutics Market Size (2021-2032) & (US$ Million) Figure 53. South Korea Veterinary Therapeutics Market Size (2021-2032) & (US$ Million) Figure 54. Taiwan Veterinary Therapeutics Market Size (2021-2032) & (US$ Million) Figure 55. Southeast Asia Veterinary Therapeutics Market Size (2021-2032) & (US$ Million) Figure 56. India Veterinary Therapeutics Market Size (2021-2032) & (US$ Million) Figure 57. Australia Veterinary Therapeutics Market Size (2021-2032) & (US$ Million) Figure 58. South America, Middle East & Africa Veterinary Therapeutics Market Size (2021-2032) & (US$ Million) Figure 59. South America, Middle East & Africa Veterinary Therapeutics Market Share by Type (2021-2032) Figure 60. South America, Middle East & Africa Veterinary Therapeutics Market Share by Application (2021-2032) Figure 61. South America, Middle East & Africa Veterinary Therapeutics Market Share by Country (2021-2032) Figure 62. Brazil Veterinary Therapeutics Market Size (2021-2032) & (US$ Million) Figure 63. South Africa Veterinary Therapeutics Market Size (2021-2032) & (US$ Million) Figure 64. Saudi Arabia Veterinary Therapeutics Market Size (2021-2032) & (US$ Million) Figure 65. Turkey Veterinary Therapeutics Market Size (2021-2032) & (US$ Million) Figure 66. Argentina Veterinary Therapeutics Market Size (2021-2032) & (US$ Million) Figure 67. UAE Veterinary Therapeutics Market Size (2021-2032) & (US$ Million) Figure 68. Egypt Veterinary Therapeutics Market Size (2021-2032) & (US$ Million) Figure 69. Chile Veterinary Therapeutics Market Size (2021-2032) & (US$ Million) Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Analgesics
  • Sedatives
  • Anti-Inflammatory
  • Parasiticides
  • Anti-Infectives
  • Others
Applications
  • Swine
  • Cattle
  • Poultry
  • Pets
  • Others
Companies covered
  • CAHIC
  • Zoetis
  • Ringpu Biology
  • Merck
  • Virbac
  • Vetoquinol
  • Phibro
  • Ouro Fino Saude
  • Orion
  • Norbrook
  • Nippon Zenyaku Kogyo
  • Huvepharma
  • Hipra
  • Farmavet-Pasteur
  • Elanco
  • Dechra
  • Ceva
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Veterinary Therapeutics Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Analgesics
  5. 1.2.3 Sedatives
  6. 1.2.4 Anti-Inflammatory
  7. 1.2.5 Parasiticides
  8. 1.2.6 Anti-Infectives
  9. 1.2.7 Others
  10. 1.3 Market Analysis by Application
  11. 1.3.1 Global Veterinary Therapeutics Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  12. 1.3.2 Swine
  13. 1.3.3 Cattle
  14. 1.3.4 Poultry
  15. 1.3.5 Pets
  16. 1.3.6 Others
  17. 1.4 Global Market Growth Prospects
  18. 1.5 Global Veterinary Therapeutics Growth Trends by Region
  19. 1.5.1 Global Veterinary Therapeutics Market Size by Region: 2021 VS 2025 VS 2032
  20. 1.5.2 Veterinary Therapeutics Market Size by Region (2021-2026)
  21. 1.5.3 Veterinary Therapeutics Market Size by Region (2027-2032)
  22. 1.6 Assumptions and Limitations
  23. 1.7 Study Goals and Objectives
  24. 1.8 Years Considered
2 Global Veterinary Therapeutics Market Dynamics
  1. 2.1 Veterinary Therapeutics Industry Trends
  2. 2.2 Veterinary Therapeutics Industry Drivers
  3. 2.3 Veterinary Therapeutics Industry Opportunities and Challenges
  4. 2.4 Veterinary Therapeutics Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Veterinary Therapeutics Revenue by Company (2021-2026)
  2. 3.2 Global Veterinary Therapeutics Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Veterinary Therapeutics Key Company Head office and Area Served
  4. 3.4 Global Veterinary Therapeutics Company, Product Type & Application
  5. 3.5 Global Veterinary Therapeutics Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Veterinary Therapeutics Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Veterinary Therapeutics Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Veterinary Therapeutics Tier 1, Tier 2, and Tier 3
4 Veterinary Therapeutics Market by Type
  1. 4.1 Global Veterinary Therapeutics Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Veterinary Therapeutics Market Size by Type (2021-2032)
  3. 4.3 Global Veterinary Therapeutics Market Size Share by Type (2021-2032)
5 Veterinary Therapeutics Market by Application
  1. 5.1 Global Veterinary Therapeutics Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Veterinary Therapeutics Market Size by Application (2021-2032)
  3. 5.3 Global Veterinary Therapeutics Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 CAHIC
  2. 6.1.1 CAHIC Company Information
  3. 6.1.2 CAHIC Business Overview
  4. 6.1.3 CAHIC Veterinary Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 CAHIC Veterinary Therapeutics Product Portfolio
  6. 6.1.5 CAHIC Recent Developments
  7. 6.2 Zoetis
  8. 6.2.1 Zoetis Company Information
  9. 6.2.2 Zoetis Business Overview
  10. 6.2.3 Zoetis Veterinary Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Zoetis Veterinary Therapeutics Product Portfolio
  12. 6.2.5 Zoetis Recent Developments
  13. 6.3 Ringpu Biology
  14. 6.3.1 Ringpu Biology Company Information
  15. 6.3.2 Ringpu Biology Business Overview
  16. 6.3.3 Ringpu Biology Veterinary Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Ringpu Biology Veterinary Therapeutics Product Portfolio
  18. 6.3.5 Ringpu Biology Recent Developments
  19. 6.4 Merck
  20. 6.4.1 Merck Company Information
  21. 6.4.2 Merck Business Overview
  22. 6.4.3 Merck Veterinary Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Merck Veterinary Therapeutics Product Portfolio
  24. 6.4.5 Merck Recent Developments
  25. 6.5 Virbac
  26. 6.5.1 Virbac Company Information
  27. 6.5.2 Virbac Business Overview
  28. 6.5.3 Virbac Veterinary Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Virbac Veterinary Therapeutics Product Portfolio
  30. 6.5.5 Virbac Recent Developments
  31. 6.6 Vetoquinol
  32. 6.6.1 Vetoquinol Company Information
  33. 6.6.2 Vetoquinol Business Overview
  34. 6.6.3 Vetoquinol Veterinary Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Vetoquinol Veterinary Therapeutics Product Portfolio
  36. 6.6.5 Vetoquinol Recent Developments
  37. 6.7 Phibro
  38. 6.7.1 Phibro Company Information
  39. 6.7.2 Phibro Business Overview
  40. 6.7.3 Phibro Veterinary Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Phibro Veterinary Therapeutics Product Portfolio
  42. 6.7.5 Phibro Recent Developments
  43. 6.8 Ouro Fino Saude
  44. 6.8.1 Ouro Fino Saude Company Information
  45. 6.8.2 Ouro Fino Saude Business Overview
  46. 6.8.3 Ouro Fino Saude Veterinary Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Ouro Fino Saude Veterinary Therapeutics Product Portfolio
  48. 6.8.5 Ouro Fino Saude Recent Developments
  49. 6.9 Orion
  50. 6.9.1 Orion Company Information
  51. 6.9.2 Orion Business Overview
  52. 6.9.3 Orion Veterinary Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Orion Veterinary Therapeutics Product Portfolio
  54. 6.9.5 Orion Recent Developments
  55. 6.10 Norbrook
  56. 6.10.1 Norbrook Company Information
  57. 6.10.2 Norbrook Business Overview
  58. 6.10.3 Norbrook Veterinary Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Norbrook Veterinary Therapeutics Product Portfolio
  60. 6.10.5 Norbrook Recent Developments
  61. 6.11 Nippon Zenyaku Kogyo
  62. 6.11.1 Nippon Zenyaku Kogyo Company Information
  63. 6.11.2 Nippon Zenyaku Kogyo Business Overview
  64. 6.11.3 Nippon Zenyaku Kogyo Veterinary Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Nippon Zenyaku Kogyo Veterinary Therapeutics Product Portfolio
  66. 6.11.5 Nippon Zenyaku Kogyo Recent Developments
  67. 6.12 Huvepharma
  68. 6.12.1 Huvepharma Company Information
  69. 6.12.2 Huvepharma Business Overview
  70. 6.12.3 Huvepharma Veterinary Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Huvepharma Veterinary Therapeutics Product Portfolio
  72. 6.12.5 Huvepharma Recent Developments
  73. 6.13 Hipra
  74. 6.13.1 Hipra Company Information
  75. 6.13.2 Hipra Business Overview
  76. 6.13.3 Hipra Veterinary Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Hipra Veterinary Therapeutics Product Portfolio
  78. 6.13.5 Hipra Recent Developments
  79. 6.14 Farmavet-Pasteur
  80. 6.14.1 Farmavet-Pasteur Company Information
  81. 6.14.2 Farmavet-Pasteur Business Overview
  82. 6.14.3 Farmavet-Pasteur Veterinary Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Farmavet-Pasteur Veterinary Therapeutics Product Portfolio
  84. 6.14.5 Farmavet-Pasteur Recent Developments
  85. 6.15 Elanco
  86. 6.15.1 Elanco Company Information
  87. 6.15.2 Elanco Business Overview
  88. 6.15.3 Elanco Veterinary Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Elanco Veterinary Therapeutics Product Portfolio
  90. 6.15.5 Elanco Recent Developments
  91. 6.16 Dechra
  92. 6.16.1 Dechra Company Information
  93. 6.16.2 Dechra Business Overview
  94. 6.16.3 Dechra Veterinary Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Dechra Veterinary Therapeutics Product Portfolio
  96. 6.16.5 Dechra Recent Developments
  97. 6.17 Ceva
  98. 6.17.1 Ceva Company Information
  99. 6.17.2 Ceva Business Overview
  100. 6.17.3 Ceva Veterinary Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Ceva Veterinary Therapeutics Product Portfolio
  102. 6.17.5 Ceva Recent Developments
  103. 6.18 Boehringer Ingelheim
  104. 6.18.1 Boehringer Ingelheim Company Information
  105. 6.18.2 Boehringer Ingelheim Business Overview
  106. 6.18.3 Boehringer Ingelheim Veterinary Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Boehringer Ingelheim Veterinary Therapeutics Product Portfolio
  108. 6.18.5 Boehringer Ingelheim Recent Developments
7 North America
  1. 7.1 North America Veterinary Therapeutics Market Size (2021-2032)
  2. 7.2 North America Veterinary Therapeutics Market Size by Type
  3. 7.2.1 North America Veterinary Therapeutics Market Size by Type (2021-2026)
  4. 7.2.2 North America Veterinary Therapeutics Market Size by Type (2027-2032)
  5. 7.2.3 North America Veterinary Therapeutics Market Share by Type (2021-2032)
  6. 7.3 North America Veterinary Therapeutics Market Size by Application
  7. 7.3.1 North America Veterinary Therapeutics Market Size by Application (2021-2026)
  8. 7.3.2 North America Veterinary Therapeutics Market Size by Application (2027-2032)
  9. 7.3.3 North America Veterinary Therapeutics Market Share by Application (2021-2032)
  10. 7.4 North America Veterinary Therapeutics Market Size by Country
  11. 7.4.1 North America Veterinary Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Veterinary Therapeutics Market Size by Country (2021-2026)
  13. 7.4.3 North America Veterinary Therapeutics Market Size by Country (2027-2032)
  14. 7.4.4 North America Veterinary Therapeutics Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Veterinary Therapeutics Market Size (2021-2032)
  2. 8.2 Europe Veterinary Therapeutics Market Size by Type
  3. 8.2.1 Europe Veterinary Therapeutics Market Size by Type (2021-2026)
  4. 8.2.2 Europe Veterinary Therapeutics Market Size by Type (2027-2032)
  5. 8.2.3 Europe Veterinary Therapeutics Market Share by Type (2021-2032)
  6. 8.3 Europe Veterinary Therapeutics Market Size by Application
  7. 8.3.1 Europe Veterinary Therapeutics Market Size by Application (2021-2026)
  8. 8.3.2 Europe Veterinary Therapeutics Market Size by Application (2027-2032)
  9. 8.3.3 Europe Veterinary Therapeutics Market Share by Application (2021-2032)
  10. 8.4 Europe Veterinary Therapeutics Market Size by Country
  11. 8.4.1 Europe Veterinary Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Veterinary Therapeutics Market Size by Country (2021-2026)
  13. 8.4.3 Europe Veterinary Therapeutics Market Size by Country (2027-2032)
  14. 8.4.4 Europe Veterinary Therapeutics Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Veterinary Therapeutics Market Size (2021-2032)
  2. 9.2 China Veterinary Therapeutics Market Size by Type
  3. 9.2.1 China Veterinary Therapeutics Market Size by Type (2021-2026)
  4. 9.2.2 China Veterinary Therapeutics Market Size by Type (2027-2032)
  5. 9.2.3 China Veterinary Therapeutics Market Share by Type (2021-2032)
  6. 9.3 China Veterinary Therapeutics Market Size by Application
  7. 9.3.1 China Veterinary Therapeutics Market Size by Application (2021-2026)
  8. 9.3.2 China Veterinary Therapeutics Market Size by Application (2027-2032)
  9. 9.3.3 China Veterinary Therapeutics Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Veterinary Therapeutics Market Size (2021-2032)
  2. 10.2 Asia Veterinary Therapeutics Market Size by Type
  3. 10.2.1 Asia Veterinary Therapeutics Market Size by Type (2021-2026)
  4. 10.2.2 Asia Veterinary Therapeutics Market Size by Type (2027-2032)
  5. 10.2.3 Asia Veterinary Therapeutics Market Share by Type (2021-2032)
  6. 10.3 Asia Veterinary Therapeutics Market Size by Application
  7. 10.3.1 Asia Veterinary Therapeutics Market Size by Application (2021-2026)
  8. 10.3.2 Asia Veterinary Therapeutics Market Size by Application (2027-2032)
  9. 10.3.3 Asia Veterinary Therapeutics Market Share by Application (2021-2032)
  10. 10.4 Asia Veterinary Therapeutics Market Size by Country
  11. 10.4.1 Asia Veterinary Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Veterinary Therapeutics Market Size by Country (2021-2026)
  13. 10.4.3 Asia Veterinary Therapeutics Market Size by Country (2027-2032)
  14. 10.4.4 Asia Veterinary Therapeutics Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Veterinary Therapeutics Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Veterinary Therapeutics Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Veterinary Therapeutics Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Veterinary Therapeutics Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Veterinary Therapeutics Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Veterinary Therapeutics Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Veterinary Therapeutics Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Veterinary Therapeutics Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Veterinary Therapeutics Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Veterinary Therapeutics Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Veterinary Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Veterinary Therapeutics Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Veterinary Therapeutics Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Veterinary Therapeutics Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst